ha
reporting
tissue
basel
site
baitz
health
one
both
chemotherapy
all
bode
camera
sensitivity
title
large
journal
oncol
transfer
aca
kanellopoulo
tetradecapeptide
figure
used
writing
293
esophageal
web
PT
men
cheng
liu
abdominal
revised
481
intestine
bia
REFERENCES
reactor
area
commentarie
PEG3
bearing
above
radiopeptide
institutional
micropet
keamanan
received
released
bromińska
development
injection
czepczynski
result
without
known
285
protocol
glu
body
janota
undergo
estimate
kaloudi
tool
focused
rapidly
plasma
dose
complexe
konijnenberg
185
FS
bernhardt
novel
213bi
oncology
KEYWORDS
CA
response
apply
terminal
entire
synthesized
vicrostatin
rahbar
chemistry
tolerated
tolerability
miller
tagged
secreted
since
siegel
material
cancer
multi
mueller
variou
linker
give
tolmachev
aim
RGD
disease
SM
several
critical
worse
keyword
systematic
kanker
written
include
evaluation
nock
419
made
lung
they
english
human
com
number
NP
terbium
stage
side
preferred
HAV
barbato
vivo
chem
estimated
concept
radiotracer
bioconjug
synthesi
GRPR
overview
laversanne
study
2020
category
pharmacy
disorder
WHO
promising
targeting
clin
doctor
scardino
grow
bombesin
website
it
showed
DO3A
67ga
levartovsky
ID
umbricht
heinzel
1919
KA
useful
had
than
SCID
recepto
expected
detailed
filtered
worldwide
gonen
september
currently
131I
2019
beattie
aharon
safety
BE
murni
because
open
quality
cell
life
present
therapeutic
biol
specific
aimed
ed
soerjomataram
chose
outcome
patient
roger
such
getting
linear
molecule
rep
asses
ıncidence
year
science
burden
non
obat
PC
410
amsterdam
2021
tschan
α5β1
radiopeptida
destructive
publication
touijer
inf
klette
model
obtained
tumor
food
find
using
related
two
excellent
lymphatic
effendi
more
conducting
leu
orlova
vorobyova
december
there
MDPI
january
accumulation
vitro
labeled
int
will
receptor
200
dan
acid
PET
mbq
TJS
weber
zhu
detect
pubmed
state
alpha
pharmacokinetic
pu
injected
kemeterian
endocrine
selection
name
frequently
terapi
author
provide
MNP
gili
our
node
tabulated
integrin
RESULTS
investigation
throughout
important
information
120
prospective
text
releasing
propertie
90Y
tian
2022
along
diagnosi
gadot
developing
megabecquerel
www
use
common
increase
radio
BBN
schibli
route
7695
profile
INTRODUCTION
people
scientific
bray
fragment
radiolabeled
examination
internalization
beta
GN
effort
treat
addition
reported
description
64cu
gastrointestinal
superior
processe
affect
gastrin
candidate
specialty
dengan
evaluated
lutetium
eligible
interpretation
world
purpose
αvβ5
vincro
presented
bloi
criteria
review
generator
124I
EP
death
CONCLUSION
neuropeptide
med
including
dalm
similar
clinical
haim
only
211at
massspeg2
out
menangani
METHODOLOGY
dphe6
front
meng
krieger
ABSTRACT
PEG2
pharmaceutical
theranostic
sar
treatment
million
time
language
tract
buletin
organization
rinne
agonist
mikołajczak
2018
breast
visualized
161
pharm
SU
malki
park
evidence
qualitative
99mtc
among
oncologist
regulatory
maecke
2030
lymph
multicenter
elsevier
heart
sandler
characterized
resonance
netherland
787
ability
collection
focusing
continue
obtain
search
173
michaud
identified
design
soerensen
cause
small
activity
111in
jemal
5093
antagonist
organ
DGA
inclusion
older
interest
location
new
especially
sung
literature
deposition
overexpressed
radiotherapeutic
AMA
meulen
different
statistic
direct
exhibited
also
highest
developed
data
diebolder
neobomb1
some
N4
pellegrini
nurmaya
emitter
conflict
functional
identify
application
tedesco
pancrea
manuscript
accepted
jacobson
etc
through
325
xenograft
containing
applied
affinity
retention
domachevsky
imaging
term
not
neuron
asa
statement
observed
sabahnoo
abouzayed
GLOBOCAN
nuclear
schmidt
pelvic
frontier
mixed
castration
below
radioisotope
161tb
determine
davidson
investigated
ED
singh
mainly
valuable
published
indonesia
further
list
severity
simultaneously
last
great
giarika
225ac
after
system
mol
177
most
CT
publicly
located
nucl
kesehat
schehr
hricak
PJ
PEG
adverse
modification
reselected
evidenced
analog
countrie
velikyan
millicurie
muzakkir
SPECT
unit
captured
paper
following
growing
accurately
brain
182
prolonged
FDA
malignancy
often
alara
240
RI
worldwile
approved
database
pangribowo
berger
koester
jadvar
well
wa
lymperi
pair
combined
commonly
emitting
item
617
like
nanomedicine
visualization
affibody
membrane
long
level
1575
IL
yordanova
JR
PEG3RM26
firstly
represent
good
compound
meta
18F
7685
but
particulate
177lu
molecular
amount
universita
128
carrying
NOTA
JA
1569
resistant
masss
magnetic
86Y
maina
computed
NE
them
nurmaya82
visual
metastatic
overexpressing
target
emitted
awaludin
501
quantitative
RM2
mci
gracheva
method
BA
ahmadzadehfar
abnormal
MRI
bandara
MW
2017
charged
neobomb
radiopharmaceutical
cai
local
exces
MD
bakker
however
okarvi
fani
marked
vβ3
zeevaart
statin
chimeric
respectively
calibrator
corresponding
identification
therapy
compared
primary
conducted
guo
sar11
swenson
liver
theranosti
acces
neurologic
chen
visible
reliable
exhibit
markland
indonesian
specificity
BAY86
bivalent
pharmaceutic
global
KD
hour
detected
pca
tracer
yap
mild
PPMN
beban
alvarez
radiofarmaka
toujier
oedegaard
detection
mail
high
uptake
212bi
radionuclide
gmail
act
depend
gamma
http
research
792
need
uncontrollably
invade
administration
chernov
2014
mortality
effect
carried
locating
better
biodistribution
volume
RL
nasution
diagnosed
2006
included
case
declared
RM26
supervision
faculty
low
wen
penggunaan
RP
drug
repository
deliver
risk
PRISMA
yang
emission
diagnose
kossatz
xia
urol
BBN7
radiation
allow
mediastinal
HR
hand
between
monomer
medical
closed
increasing
second
lang
other
2447
ahx
radioligand
7548
prostate
pmol
disintegrin
targeted
VCN
medicine
WA
eur
contrast
2012
image
their
DB15
ben
clearly
editorial
carrier
section
salsabilah
2016
photon
reynold
DISCUSSION
concentration
another
utilized
almost
wong
syabrina
evaluate
LET
meanwhile
called
doeswijk
radioactively
characteristic
sex
contribution
iżycki
baum
188re
68ga
group
299
same
90231
tomography
move
583309
analysi
166
miao
untuk
neobo
249
ferlay
performed
while
first
particle
smith
mice
studie
scanning
saad
future
viabilitie
antibodie
sep
point
pattern
makassar
newly
article
full
antigen
ligand
namely
single
leibowitz
radioactivity
MB1
mean
zhou
soepra
min
type
absence
1334
jong
rosilawati
radiolabelled
lyaschenko
still
stability
cyclotron
damaging
retrospective
PSMA
should
peptide
radiotheranostic
perspective
diagnostic
krenning
very
claesener
matched
under
exclusion
processing
nhet13
then
department
209
found
based
easily
ACS
amino
preclinical
produced
available
bandari
binding
diagnosa
kulkarni
develop
goe
screening
positron
230
power
surgery
distribution
muslim
orlandi
eppard
umi
around
ımaging
reduced
presence
VJ
wang
PIP
186re
eastham
relevant
potential
show
agent
enhanced
undertaken
mases
67cu
kind
secondly
flow
disappeared
LP
energy
minimal
explored
chart
1930
gopalan
CJ
engine
niu
weight
table
yung
combination
absorption
riskesda
SES
searching